[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "phone": "647 865 8622", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ryan E. S. K. Cheung B.Com., CA, CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 83074, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 168432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & VP of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emer  Leahy M.B.A., Ph.D.", "age": 58, "title": "Consultant", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen D. Collins M.D., Ph.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.89, "open": 33.51, "dayLow": 33.3, "dayHigh": 37.54, "regularMarketPreviousClose": 33.89, "regularMarketOpen": 33.51, "regularMarketDayLow": 33.3, "regularMarketDayHigh": 37.54, "payoutRatio": 0.0, "beta": 0.494, "volume": 30087, "regularMarketVolume": 30087, "averageVolume": 89691, "averageVolume10days": 61640, "averageDailyVolume10Day": 61640, "bid": 36.08, "ask": 38.54, "bidSize": 1, "askSize": 1, "marketCap": 262318192, "fiftyTwoWeekLow": 0.93, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 37.6834, "twoHundredDayAverage": 18.908106, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 204604224, "forwardPE": -8.478088, "profitMargins": 0.0, "floatShares": 2593597, "sharesOutstanding": 7043990, "sharesShort": 126420, "sharesShortPriorMonth": 172036, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0179, "heldPercentInsiders": 0.22356, "heldPercentInstitutions": 0.72511, "shortRatio": 1.45, "shortPercentOfFloat": 0.026400002, "impliedSharesOutstanding": 7223780, "bookValue": 8.274, "priceToBook": 4.500846, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -1068069, "trailingEps": -0.14, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 18.818714, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 37.24, "targetHighPrice": 91.10351, "targetLowPrice": 91.10351, "targetMeanPrice": 91.10351, "targetMedianPrice": 91.10351, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 57896664, "totalCashPerShare": 8.219, "totalDebt": 182733, "quickRatio": 125.592, "currentRatio": 126.151, "debtToEquity": 0.316, "returnOnAssets": -0.04926, "returnOnEquity": -0.03345, "freeCashflow": -1400343, "operatingCashflow": -2522493, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "DRUG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Bright Minds Biosciences Inc.", "corporateActions": [], "postMarketTime": 1740780133, "regularMarketTime": 1740776402, "exchange": "NCM", "regularMarketChangePercent": 9.884929, "regularMarketPrice": 37.24, "marketState": "CLOSED", "longName": "Bright Minds Biosciences Inc.", "messageBoardId": "finmb_691048918", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616419800000, "postMarketChangePercent": 0.0, "postMarketPrice": 37.24, "postMarketChange": 0.0, "regularMarketChange": 3.3500023, "regularMarketDayRange": "33.3 - 37.54", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 89691, "fiftyTwoWeekLowChange": 36.31, "fiftyTwoWeekLowChangePercent": 39.04301, "fiftyTwoWeekRange": "0.93 - 79.02", "fiftyTwoWeekHighChange": -41.779995, "fiftyTwoWeekHighChangePercent": -0.5287269, "fiftyTwoWeekChangePercent": 1881.8715, "epsTrailingTwelveMonths": -0.14, "epsCurrentYear": -2.2, "priceEpsCurrentYear": -16.927273, "fiftyDayAverageChange": -0.44339752, "fiftyDayAverageChangePercent": -0.011766389, "twoHundredDayAverageChange": 18.331896, "twoHundredDayAverageChangePercent": 0.96952575, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-08", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Bright Minds Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]